FDA label 159e9ddd-d861-453b-8bf0-c2a0d603fd7c

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
6f079fa9-2fa2-4988-ae1b-46b8fd670fac
SPL ID
159e9ddd-d861-453b-8bf0-c2a0d603fd7c
Version
1
Effective date
2016-01-19
Source export date
2026-11-06
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/245ea1c0d730b312e4410f082201cbe2cb4d1936fa2918316b6ea631293cbeba/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 08:06:14

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings FOR EXTERNAL USE ONLY Consult a physician before use if you have a condition that covers a large area of the body. Consult a physician or pharmacist before using if you intend to use this product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs. When using this product: • Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water. • If improvement does not occur, or condition worsens after regular use, as directed, consult a physician. • Use caution when exposing skin to sunlight after using this product. It may increase the tendency to sunburn for up to 24 hours after using this product. • Do not use for prolonged periods without consulting a doctor. If condition worsens or does not improve after regular use of this product as directed, stop use and consult a physician.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.